HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore Sells 8,881 Shares

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

HealthEquity Trading Down 3.8 %

Shares of HealthEquity stock opened at $79.94 on Friday. The company has a market cap of $6.91 billion, a price-to-earnings ratio of 73.34, a PEG ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company’s fifty day simple moving average is $98.22 and its 200-day simple moving average is $96.27. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HQY. KeyCorp cut their price target on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Monday, March 24th. The Goldman Sachs Group cut their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Wells Fargo & Company upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday, March 14th. Finally, Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their target price for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $112.58.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in HQY. Arcadia Investment Management Corp MI bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $26,000. Versant Capital Management Inc bought a new stake in HealthEquity in the 1st quarter valued at $28,000. Transce3nd LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at $29,000. Smartleaf Asset Management LLC lifted its holdings in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares during the period. Finally, Proficio Capital Partners LLC acquired a new stake in shares of HealthEquity during the 4th quarter valued at about $39,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.